ActiGraph

Technology/Service ProviderPrivate Company
Pensacola, Florida, United States
2004
Founded
50-200
Employees
230
Trials supported

About ActiGraph

ActiGraph is pioneering the digital transformation of clinical research. Our medical-grade wearable technology solutions have been used to capture real-world, continuous digital measures of sleep, activity, and mobility for 230 industry-sponsored clinical trials and thousands of academic research studies across a wide range of therapeutic areas. Appearing in over 22,000 peer-reviewed scientific publications, ActiGraph is the most experienced wearable technology partner in the industry.

Services

Therapeutic areas

Experience & capabilities

Trial phases:Phase 1Phase 2Phase 3Phase 4
Products:Class II Medical Devices
Trial geography:Global
Compliance:Audited by FDAGDPR compliant21 CFR Part 11 compliant

Team

  • Jeremy WyattChief Executive Officer
  • Christine Guo, PhDChief Scientific Officer
  • Kim RejndrupChief Product Officer

Browse companies by location

Pensacola, United StatesUnited States

Similar Technology/Service Provider companies in United States

1nHealth

Technology/Service Provider
Orlando, United States·10-50 employees

If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…

26FIVE Global Lab

Technology/Service Provider
New York, United States·50-200 employees

Amplity Health

Technology/Service Provider
Yardley, United States·500-5,000 employees

Bios Health Group

Technology/Service Provider
Duluth, United States·1-10 employees

Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…

Block Clinical Inc.

Technology/Service Provider
San Diego, United States·10-50 employees

Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…